SCHEMBL7213156

SCHEMBL7213156

O=C(Nc1ccc(Br)cc1)c1cc(Br)ccc1NS(=O)(=O)Cc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC10A2 Q12908 1/20 0.55
SLC10A1 Q14973 1/20 0.55
SLC10A6 Q3KNW5 1/20 0.55
GPR27 Q9NS67 4/20 0.49
AVPR2 P30518 1/20 0.49
ACLY P53396 1/20 0.47
RAB9A P51151 2/20 0.47
NPC1 O15118 1/20 0.47
MAPT P10636 4/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
TP53 P04637 2/20 0.46
ALDH1A1 P00352 2/20 0.45
HPGD P15428 1/20 0.45
HDAC1 Q13547 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
EGFR P00533 1/20 0.44
LMNA P02545 1/20 0.44
ERBB2 P04626 1/20 0.44
CYP1A2 P05177 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27596915 0.85 SLC10A2 (0.50) SLC10A2SLC10A1SLC10A6GPR27AVPR2
SCHEMBL7120319 0.81 SLC10A6 (0.76) SLC10A2SLC10A1SLC10A6GPR27AVPR2
SCHEMBL7209253 0.79 SLC10A2 (0.55) SLC10A2SLC10A1SLC10A6GPR27RAB9A
SCHEMBL7114742 0.79 SLC10A6 (0.58) SLC10A2SLC10A1SLC10A6GPR27AVPR2
SCHEMBL7117439 0.78 SLC10A2 (0.63) SLC10A2SLC10A1SLC10A6GPR27AVPR2
SCHEMBL7213023 0.78 SLC10A6 (0.73) SLC10A2SLC10A1SLC10A6GPR27AVPR2
SCHEMBL7213183 0.78 SLC10A6 (0.73) SLC10A2SLC10A1SLC10A6GPR27AVPR2
SCHEMBL7116008 0.77 SLC10A6 (0.85) SLC10A2SLC10A1SLC10A6GPR27AVPR2
SCHEMBL7629312 0.77 SLC10A2 (0.53) SLC10A2SLC10A1SLC10A6GPR27AVPR2
SCHEMBL7629313 0.77 SLC10A2 (0.53) SLC10A2SLC10A1SLC10A6GPR27AVPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1187531-A4 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2003-05-28 EP claimed
US-6458845-B1 METHOD OF ANTAGONIZING A MACROPHAGE SCAVENGER RECEPTOR COMPRISING ADMINISTERING TO A SUBJECT IN NEED OF TREATMENT AN EFFECTIVE AMOUNT OF AN N-PHENYL-2-(3-TRIFLUOROMETHYLPHENYLSULFONAMIDO)BENZAMIDE, A SMITHKLINE BEECHAM CORPORATION 2002-10-01 US claimed
CN-1358062-A Macrophage scavenger receptor antagonists SMITHKLINE BEECHAM CORP (US) 2002-07-10 CN claimed
EP-1187531-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SmithKline Beecham Corporation (US) 2002-03-20 EP claimed
WO-2001098264-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-27 WO claimed
WO-2000078145-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2000-12-28 WO claimed
US-6458845-B1 METHOD OF ANTAGONIZING A MACROPHAGE SCAVENGER RECEPTOR COMPRISING ADMINISTERING TO A SUBJECT IN NEED OF TREATMENT AN EFFECTIVE AMOUNT OF AN N-PHENYL-2-(3-TRIFLUOROMETHYLPHENYLSULFONAMIDO)BENZAMIDE, A SMITHKLINE BEECHAM CORPORATION 2002-10-01 US disclosed
CN-1358062-A Macrophage scavenger receptor antagonists SMITHKLINE BEECHAM CORP (US) 2002-07-10 CN disclosed
WO-2001098264-A1 MACROPHAGE SCAVENGER RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 2001-12-27 WO disclosed